Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Abstract Over the past 5 years, public interest in the potential health benefits of cannabidiol (CBD) has increased exponentially, and…
Abstract Over the past 5 years, public interest in the potential health benefits of cannabidiol (CBD) has increased exponentially, and…
Abstract Question: Does use of high-potency cannabis (compared with use of low-potency cannabis) increase risks for problems resulting from cannabis…
Abstract Epidemiological and biological evidence support the association between heavy cannabis use and psychosis. However, it is unclear which cannabis…
Abstract Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its safety.…
Abstract The laws governing cannabis are evolving worldwide and associated with changing patterns of use. The main psychoactive drug in…
Abstract Aims: To quantify changes in (i) potency (concentration of Δ9‐tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value…
Abstract The main active ingredient in cannabis, delta-9-tetrahydrocannabinol (THC), can acutely induce psychotic symptoms and impair episodic and working memory.…
Abstract Background: Changes in cannabis regulation globally make it increasingly important to determine what predicts an individual’s risk of experiencing…
Abstract Background and Aims: Cannabidiol (CBD), a non‐intoxicating cannabinoid found in cannabis, may be a promising novel smoking cessation treatment…
Abstract Introduction: Major gaps exist in the measurement of cannabis exposure. The accuracy of self-reported cannabis and tobacco dose per…